TL;DR
- •Mirtazapine increases appetite in a large share of patients, and the effect usually begins within the first week, often before any mood benefit appears.
- •The hunger is driven by potent histamine H1 receptor blockade plus 5-HT2C receptor antagonism, which is a direct pharmacological appetite signal rather than a lapse in self-control.
- •H1 receptor affinity is the single best predictor of which antidepressants cause weight gain, and mirtazapine has among the highest H1 affinity of any antidepressant in clinical use.
- •Cravings skew heavily toward carbohydrates and tend to peak in the evening, because mirtazapine is dosed at night and sedation lowers the resistance to eating.
- •The appetite effect does not reliably fade with time on its own, so waiting it out is usually the least effective strategy.
- •Higher doses are sometimes less sedating and less appetite-driving than low doses, because noradrenergic activity increases enough to partly offset H1 blockade. This is worth raising with a prescriber before abandoning the drug.
- •If mirtazapine is working for mood and sleep but the appetite is intolerable, the realistic options are dose adjustment, structured countermeasures, or a mechanism switch, not willpower.
Medications most associated with this
What this is
Patients describe it as a hunger that feels physical and urgent rather than an ordinary appetite. Common accounts include waking in the night to eat, finishing a full meal and still feeling empty, and a specific pull toward bread, pasta, cereal, sweets, and other fast carbohydrates. The drive is strongest in the evening, which is when mirtazapine is typically taken. Many patients report that the hunger feels different from normal hunger: it is harder to reason with, it does not settle after eating, and it can persist even when the stomach is uncomfortably full. Patients often describe real distress about this, particularly when the medication is genuinely helping their depression and sleep.
Why it happens
Mirtazapine is a potent histamine H1 receptor antagonist, and H1 blockade is a well-established appetite and weight signal. A comparative analysis across antidepressants found that H1 receptor affinity predicts weight gain better than any other receptor property, and mirtazapine sits at the high end of that range. Mirtazapine also blocks 5-HT2C receptors, which removes a serotonergic brake on feeding, so two separate appetite-promoting mechanisms operate at once. This combination is the same reason mirtazapine is deliberately prescribed as an appetite stimulant in other settings, including cancer-related anorexia. Systematic review of mirtazapine adverse events in major depressive disorder confirms increased appetite and weight gain as among the most consistently reported effects. The clinically important point for patients is that this is a receptor-level effect, not a behavioral failure.
Typical timeline
Onset is fast, usually within the first three to seven days, and frequently precedes any antidepressant benefit. That mismatch is part of why the side effect feels so discouraging early on. The appetite drive commonly stays present for as long as the drug is continued, although some patients report partial adaptation over several months. Weight change tends to be front-loaded, with the largest gains in the first eight to twelve weeks. Because the effect is dose-related in a non-linear way, some patients find that moving from 7.5 mg or 15 mg up to 30 mg or 45 mg reduces both sedation and appetite, since increased noradrenergic transmission at higher doses partially offsets the antihistamine effect. Appetite typically normalizes within a few weeks of stopping the medication.
Management options
Discuss with your prescriber before adjusting any medication. These are options to bring up in conversation.
Ask about a dose increase before quitting
This is counterintuitive and frequently missed. Mirtazapine is most sedating and most appetite-driving at low doses. At 30 mg to 45 mg, noradrenergic and serotonergic activity rises enough to partly offset H1 blockade, and some patients find both sedation and hunger improve. Never adjust the dose without the prescriber, but do raise the question rather than assuming the only path is off the drug.
Structure the evening rather than resisting it
Because the drive peaks after the night-time dose, the practical countermeasure is to decide what is available before the dose rather than trying to win an argument with the hunger afterward. Pre-portioned protein-heavy snacks, not keeping fast carbohydrates in the house, and eating a substantial dinner before dosing all reduce the total intake more reliably than willpower at 11 pm.
Take the dose closer to bedtime
Shortening the window between dosing and sleep reduces the amount of waking time spent under peak sedation and peak appetite drive. This is a small change that some patients find meaningfully reduces night eating.
Track weight rather than avoiding the scale
Weight gain on mirtazapine is front-loaded, so early detection matters. Weekly weighing gives a prescriber the information needed to decide whether to adjust before a large change accumulates. Avoiding the scale tends to delay the conversation until the gain is harder to reverse.
Switch within the antidepressant class
If mirtazapine is helping mood but appetite is intolerable, agents with low H1 affinity carry substantially less appetite and weight risk. This is a straightforward conversation to have with a prescriber, and the H1 affinity data gives a rational basis for the choice.
Mechanism switch to ketamine
For patients who came to mirtazapine after other antidepressants failed, and who now face a choice between a drug that works and a side effect they cannot live with, ketamine offers an entirely different mechanism with no antihistamine activity and no appetite signal.
Where ketamine fits
Mirtazapine is often a later-line choice, reached after SSRIs or SNRIs failed or were poorly tolerated. That means the patients most troubled by the appetite effect are frequently the ones with the fewest remaining conventional options, which makes the tradeoff feel especially unfair. Ketamine acts through NMDA receptor antagonism and downstream glutamate signaling, with no meaningful histamine H1 or 5-HT2C activity, so it does not produce the appetite drive that defines this side effect. For a patient whose depression responds to mirtazapine but whose weight and eating have become their main source of distress, a mechanism switch can preserve the antidepressant benefit without the receptor profile causing the problem. This is a decision to make with a prescriber, and mirtazapine should be tapered rather than stopped abruptly.
Check eligibility for ketamine therapy5-minute screening · Reviewed by a board-certified physician · FL, NJ & CA
Frequently asked
Does the mirtazapine hunger eventually go away if I ignore it?
Usually not on its own. The appetite drive comes from ongoing H1 and 5-HT2C receptor blockade, which persists for as long as you take the drug. Some patients report partial adaptation over several months, but waiting it out is the least reliable strategy. Dose adjustment, structured countermeasures, or a switch are more likely to help.
Why would a higher dose cause less hunger, not more?
Mirtazapine has an unusual dose-response profile. At low doses the antihistamine effect dominates, producing sedation and appetite. At higher doses, noradrenergic transmission increases enough to partly counteract it. This is why some patients feel less sedated and less hungry at 30 mg than at 15 mg. It is worth asking your prescriber about, but never adjust the dose yourself.
Is the weight gain from eating more, or does mirtazapine slow metabolism?
Predominantly from increased intake. The dominant mechanism is a genuine increase in appetite and food-seeking driven by receptor blockade. That is why countermeasures aimed at what is available and when tend to work better than countermeasures aimed at trying harder.
Will my appetite return to normal if I stop mirtazapine?
For most patients, yes, typically within a few weeks of discontinuation as receptor blockade resolves. Weight already gained takes longer to address and does not reverse automatically. Do not stop mirtazapine abruptly. It should be tapered under prescriber supervision.
I need the sleep benefit. Is there any way to keep that without the appetite?
This is the common bind, since both the sedation and the appetite come from the same H1 blockade. Options include a dose change, a different sleep-supporting strategy alongside a lower-H1 antidepressant, or a mechanism switch if the underlying depression is the real target. A prescriber can separate which part of the benefit you most need to preserve.
Related reading
Don’t stop your medication on your own
Even mild side effects deserve a clinical conversation. Stopping or adjusting antidepressants without coordination with your prescriber can cause discontinuation syndrome, depression breakthrough, or both. Bring these options to your next appointment.
References
- Salvi V et al. 2016, European Neuropsychopharmacology. Histamine H1 receptor affinity predicts weight gain across antidepressants, with mirtazapine among the highest-affinity agents. PMID 27593622
- Domecq JP et al. 2015, Journal of Clinical Endocrinology and Metabolism. Systematic review and meta-analysis of drugs commonly associated with weight change, including antidepressant agents. PMID 25590213
- Kamp CB et al. 2025, BMC Psychiatry. Systematic review with meta-analysis of adverse events with mirtazapine in major depressive disorder, including increased appetite and weight gain. PMID 39844067
- Sanacora G et al. 2017, JAMA Psychiatry. Consensus statement on ketamine in mood disorders, covering use in patients who cannot tolerate standard antidepressants. PMID 28249076